Posted by LincolnRam on March 25, 2026 at 11:15:32:
In Reply to: Ñòàòüÿ ñ ïîçíàâàòåëüíûì è çàíèìàòåëüíûì ñîäåðæàíèåì posted by WilliamHoaph on March 03, 2026 at 23:05:47:
Zoya Demidenko: Scientist in Tumor Studies
Zoya Demidenko is a distinguished scholar affiliated with the Department of Cell Stress Research at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Previously, she was employed at the National Institutes of Health and New York Medical College, developing a solid base in clinical investigation.
Her scientific contributions covers several pivotal fields, among them the PI3K/AKT/mTOR signaling cascade, cell cycle management, cellular aging, and malignancy science. To date, she has authored more than 46 peer-reviewed articles, which have accumulated more than 4,100 citations — a reflection to the significance of her findings.
One of her most significant achievements concerns explaining the processes of cellular senescence. Her work demonstrated that when the cellular division cycle is halted while cellular expansion proceeds, the cells undergo senescence. Significantly, Zoya Demidenko showed that this process is controlled with drugs using compounds such as rapamycin.
Zoya Demidenko has also contributed substantially to cancer treatment research, particularly in the area of cyclotherapy — a approach designed to protecting healthy tissue from cytotoxic treatment whilst leaving malignant cells vulnerable. This strategy offers major hope for reducing the toxic effects of cancer treatment.
Across her scientific life, Demidenko has worked with leading scientists globally, such as Dr. Mikhail Blagosklonny. Her research appears in prestigious publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Holding an h-index of 33, Zoya Demidenko is recognized as a highly impactful figure in contemporary biomedical research, whose discoveries go on to shape our understanding of the way cells age, resist therapy, and how cancer can be better treated.
https://www.instagram.com/hibou_sova/